INTENDED AUDIENCE – This activity is designed for primary care physicians and psychiatrists. No prerequisites required.
ACCREDITATION– The Mount Sinai School of Medicine (MSSM) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
CREDIT DESIGNATION – The Mount Sinai School of Medicine designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
After reviewing this webcast activity, participants may receive credit by completing the CME test, evaluation, and receiving a score of 70% or higher.
VERIFICATION OF ATTENDANCE: Verification of attendance will be provided to all professionals.
ACCREDITATION STATEMENT – The Mount Sinai School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
SPECIAL NEEDS – The Mount Sinai School of Medicine is in full compliance with provisions of the Americans with Disabilities Act and is accessible for individuals with special needs. If you would like to view this activity and require any special needs or accommodations please contact the Page and William Black Post-Graduate School of Medicine at 212-731-7950.
RELEASE DATE: June 2010. EXPIRATION DATE: June 2011.
ESTIMATED TIME TO COMPLETE ACTIVITY: 1 hour 15 minutes.
This educational activity is an interactive, case-based webcast consisting of approximately 1.25 hours of fully developed, on-demand, video-based clinical content.
FACULTY DISCLOSURE – It is the policy of Mount Sinai School of Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. Presenters must also make a meaningful disclosure to the audience of their discussions of unlabeled or unapproved drugs or devices. This information will be available as part of the course material. The participating faculty reported the following:
Name of Faculty or Presenter ||Reported Financial Relationship
Jeffrey H. Newcorn, MD
Associate Professor of Psychiatry and Pediatrics
Director of the Division of Adolescent Psychiatry
Mount Sinai School of Medicine
New York, New York
Dr Newcorn reports serving as a consultant/advisor for AstraZeneca, BioBehavioral Diagnostics, Novartis Pharmaceuticals Corporation, and Schering-Plough Corporation; and serving as a consultant/advisor for and receiving research support from Eli Lilly and Company, Janssen, Ortho-McNeil Pharmaceuticals, Inc, and Shire Pharmaceuticals.
Lenard A. Adler, MD
Departments of Psychiatry and Child and Adolescent Psychiatry
New York University Medical Center
New York, New York
Dr Adler reports receiving grants/research support from and/or consulting/serving on the advisory board for AstraZeneca, Bristol-Myers Squibb Company, Chelsea Therapeutics, Inc., Eli Lilly and Company, EPI-Q, Inc, i3 Research, INC Research, Mindsite, National Institute of Drug Abuse, Organon/Schering-Plough/Merck, Inc., Ortho McNeil/Jannsen/Johnson & Johnson, Pfizer Inc, Otsuka Pharmaceuticals, and Shire Pharmaceuticals. In addition, he reports receiving royalty payments (as inventor) from New York University for license of adult ADHD scales and training materials.
OFF-LABEL PRODUCT DISCUSSION – The audience is advised that some audio content in this CME activity contains reference(s) to unlabeled or unapproved uses of drugs or devices.
Dr Adler– immediate release methylphenidate and mixed amphetamine salts.
Dr Newcorn– bupropion.
This activity is supported by an educational grant from Lilly USA, LLC. For further information concerning Lilly grant funding visit www.lillygrantoffice.com.